3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid
C19H13Cl2N3O5 — CID 155296081
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid
3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid (PubChem CID 155296081) has the molecular formula C19H13Cl2N3O5 and a molecular weight of 434.24 g/mol. Its IUPAC name is 3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid.
Molecular Properties
| Compound Name | 3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid |
|---|---|
| PubChem CID | 155296081 |
| Molecular Formula | C19H13Cl2N3O5 |
| Molecular Weight | 434.24 g/mol |
| Exact Mass | 433.02 |
| IUPAC Name | 3-[3,5-dichloro-4-[(6-oxo-5-phenyl-1H-pyridazin-3-yl)oxy]anilino]-3-oxopropanoic acid |
| SMILES | O=C(O)CC(=O)Nc1cc(Cl)c(Oc2cc(-c3ccccc3)c(=O)[nH]n2)c(Cl)c1 |
| InChI | InChI=1S/C19H13Cl2N3O5/c20-13-6-11(22-15(25)9-17(26)27)7-14(21)18(13)29-16-8-12(19(28)24-23-16)10-4-2-1-3-5-10/h1-8H,9H2,(H,22,25)(H,24,28)(H,26,27) |
| InChIKey | DCQFPOKPGHUYCL-UHFFFAOYSA-N |
| XLogP | 3.95 |
| TPSA | 121.38 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.24 |
| LogP ≤ 5 | 3.95 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155296081 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.